MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)

Phase 2
Completed
Conditions
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2012-10-25
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
300
Registration Number
NCT00000836
Locations
🇺🇸

UCSD - Shiley Eye Ctr / SOCA, La Jolla, California, United States

🇺🇸

UCLA - Jules Stein Eye Institute / SOCA, Los Angeles, California, United States

🇺🇸

UCSF - San Francisco Gen Hosp, San Francisco, California, United States

and more 3 locations

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Not Applicable
Completed
Conditions
Candidiasis
Candidiasis, Esophageal
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
400
Registration Number
NCT00000744
Locations
🇺🇸

Community Consortium of San Francisco, San Francisco, California, United States

🇺🇸

AIDS Research Alliance - Chicago, Chicago, Illinois, United States

🇺🇸

Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States

and more 13 locations

A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

Phase 1
Completed
Conditions
HIV Infections
HIV Wasting Syndrome
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
38
Registration Number
NCT00000854
Locations
🇺🇸

USC CRS, Los Angeles, California, United States

🇺🇸

Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington, District of Columbia, United States

🇺🇸

Washington U CRS, Saint Louis, Missouri, United States

and more 19 locations

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

Not Applicable
Terminated
Conditions
Lymphoma, Non-Hodgkin
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
45
Registration Number
NCT00000723
Locations
🇺🇸

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans, Louisiana, United States

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
399
Registration Number
NCT00000916
Locations
🇺🇸

Harbor-UCLA Med. Ctr. CRS, Torrance, California, United States

🇺🇸

Weiss Memorial Hosp., Chicago, Illinois, United States

🇺🇸

Massachusetts General Hospital ACTG CRS, Boston, Massachusetts, United States

and more 31 locations

An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
12
Registration Number
NCT00000650
Locations
🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Phase 1
Completed
Conditions
Bacterial Infections
Mycoses
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
48
Registration Number
NCT00000826
Locations
🇺🇸

University of Washington AIDS CRS, Seattle, Washington, United States

🇺🇸

Ucsf Aids Crs, San Francisco, California, United States

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

Phase 2
Completed
Conditions
Gastrointestinal Diseases
Cytomegalovirus Retinitis
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
850
Registration Number
NCT00001034
Locations
🇺🇸

Community Consortium of San Francisco, San Francisco, California, United States

🇺🇸

Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States

🇺🇸

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans, Louisiana, United States

and more 14 locations

A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
35
Registration Number
NCT00000855
Locations
🇺🇸

Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, United States

🇺🇸

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, United States

🇺🇸

State Univ of New York at Stony Brook, Stony Brook, New York, United States

and more 33 locations

An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy

Phase 3
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2001-08-31
Last Posted Date
2021-11-05
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
4150
Registration Number
NCT00004978
Locations
🇺🇸

Cathedral Healthcare System, St. Michael's Med. Ctr. CRS, Newark, New Jersey, United States

🇺🇸

The Early Intervention Program at Kennedy Hosp. CRS, Voorhees, New Jersey, United States

🇨🇦

Toronto Gen. Hosp. Infectious Diseases CRS, Toronto, Ontario, Canada

and more 245 locations
© Copyright 2025. All Rights Reserved by MedPath